ACE and obesity due to melanocortin 4 receptor deficiency: We observed that women with obesity had bigger differences in blood pressure when using ACE inhibitors and ARBs than normal weight and overweight women which may be expected given the known physiology of ACE inhibitors and obesity [21–23].